John Brantley, MD
Dermatology · Baton Rouge, LANPI 1629006630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 887 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.
Across 887 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Pfizer$1K
- UCB, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$988
- Johnson & Johnson$951
- Novartis$948
- plus $7K from 28 others
What the payments were for
- Food & beverage$15,38399%
- Education$1641%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 222 | $3,581 |
| Pfizer | 69 | $1,091 |
| UCB, Inc. | 59 | $1,047 |
| Regeneron Healthcare Solutions, Inc. | 45 | $988 |
| Johnson & Johnson | 48 | $951 |
| Novartis | 57 | $948 |
| Amgen | 47 | $944 |
| Galderma Laboratories, L.p. | 59 | $854 |
| Lilly USA, LLC | 33 | $692 |
| Incyte Corporation | 29 | $550 |
| Sanofi | 27 | $543 |
| LEO Pharma Inc. | 39 | $538 |
| E.r. Squibb & Sons, L.L.C. | 23 | $427 |
| Dermavant Sciences, Inc. | 31 | $395 |
| Almirall LLC | 15 | $314 |
| Sun Pharmaceutical Industries Inc. | 13 | $242 |
| Genentech USA, Inc. | 12 | $217 |
| Hill Dermaceuticals, Inc. | 2 | $211 |
| Bristol Myers Squibb | 10 | $174 |
| Arcutis Biotherapeutics, Inc. | 9 | $161 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $114 |
| Boehringer Ingelheim | 5 | $106 |
| Journey Medical Corporation | 4 | $72 |
| VYNE Pharmaceuticals Inc. | 3 | $69 |
| Dermira, Inc. | 4 | $69 |
| EPI Health, LLC | 3 | $51 |
| Mayne Pharma Commercial LLC | 3 | $43 |
| Organogenesis Inc. | 2 | $42 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Botanix SB Inc | 1 | $23 |
| Strata Skin Sciences, Inc. | 1 | $18 |
| Organon | 1 | $17 |
| Medtronic | 1 | $16 |
| Merz North America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,547 in reported general payments places this provider in the 80th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErivedgeVismodegib | 11 | $150,806 |
| Dupixent SyringeDupilumab | 14 | $52,396 |
| Fluorouracil | 182 | $11,053 |
| Ivermectin | 11 | $3,941 |
| Betamethasone Dipropionate | 77 | $3,647 |
| Mupirocin | 434 | $3,365 |
| Hydrocortisone | 267 | $3,293 |
| Clobetasol Propionate | 62 | $2,924 |
| Mometasone Furoate | 176 | $2,851 |
| Fluocinonide | 80 | $2,506 |
| Triamcinolone Acetonide | 338 | $2,270 |
| Econazole Nitrate | 90 | $1,791 |
| CiclopiroxCiclopirox Olamine | 132 | $1,634 |
| Calcipotriene | 12 | $1,377 |
| Fluocinolone Acetonide | 28 | $1,228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech USA, Inc.Erivedge | $217 | $150,80611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 189 dermatology providers in Louisiana.
Other dermatology in Baton Rouge
- Justin CreelBaton Rouge$199K
- Mamina TureganoBaton Rouge$157K
- Kelli HallBaton Rouge$31K
- Ira ThorlaBaton Rouge$31K
- Sarah McGintyBaton Rouge$18K
- Mary DickersonBaton Rouge$18K
- Amie ShannonBaton Rouge$13K
- Lori ByrdBaton Rouge$12K
- Harry BurglassBaton Rouge$11K
- Nicole HarrellBaton Rouge$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.